Oragenics (OGEN) Cash from Investing Activities (2010 - 2026)

Oragenics (OGEN) has 11 years of Cash from Investing Activities data on file, last reported at $4.0 million in Q1 2026.

• Quarterly Cash from Investing Activities changed N/A year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (changed N/A YoY) and the FY2023 annual result came in at -$936284.0, down 710.5% from the prior year.
• Cash from Investing Activities improved to $4.0 million in Q1 2026, from -$999999.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $4.0 million in Q1 2026 to a low of -$999999.0 in Q4 2023.
• A 3-year average of $576896.4 and a median of -$37034.0 in 2022 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 82.6% — and 2023, when it sank 28986.65%.
• Tracing OGEN's Cash from Investing Activities over 3 years: stood at -$3438.0 in 2022, then slumped by 28986.65% to -$999999.0 in 2023, then soared by 500.0% to $4.0 million in 2026.
• The last three Cash from Investing Activities figures came in at $4.0 million (Q1 2026), -$999999.0 (Q4 2023), and -$3438.0 (Q4 2022), per Business Quant data.